Treatment of tension-type headache with botulinum toxin type A: A double-blind, placebo-controlled study

被引:117
作者
Rollnik, JD [1 ]
Tanneberger, O
Schubert, M
Schneider, U
Dengler, R
机构
[1] Hannover Med Sch, Dept Neurol, D-30623 Hannover, Germany
[2] Hannover Med Sch, Dept Neurol & Clin Neurophysiol, D-30623 Hannover, Germany
[3] Hannover Med Sch, Dept Clin Psychiat & Psychotherapy, D-30623 Hannover, Germany
来源
HEADACHE | 2000年 / 40卷 / 04期
关键词
tension-type headache; therapy; botulinum toxin A; muscle tenderness;
D O I
10.1046/j.1526-4610.2000.00044.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective.-To determine whether injections of botulinum toxin could be of therapeutic value in the treatment of tension-type headache. Background.-Botulinum toxin A is very effective at reducing muscle tenderness and pain In many diseases. Increased muscle tension may contribute to tension-type headache. Methods.-We performed a double-blind, placebo-controlled study with 21 patients fulfilling the International Headache Society criteria for tension-type headache. Participants were randomly assigned to treatment (pericranial injection of 10 x 20 mouse units botulinum toxin A) or placebo (injection of isotonic saline in the same manner). Results.-After 4, 8, and 12 weeks, no significant differences between placebo and treatment could he observed (with respect to visual analog scale, frequency and duration of headache attacks, consumption of analgesics, pressure pain threshold, total tenderness score, and quality-of-life parameters). Conclusions.-The findings of our study strongly support the hypothesis that peripheral mechanisms, such as increased muscle tenderness, only play a minor role in the pathogenesis of tension-type headache.
引用
收藏
页码:300 / 305
页数:6
相关论文
共 27 条
[1]   TREATMENT OF MYOFASCIAL PAIN WITH BOTULINUM-A TOXIN [J].
ACQUADRO, MA ;
BORODIC, GE .
ANESTHESIOLOGY, 1994, 80 (03) :705-706
[2]   LOCALIZED INJECTIONS OF BOTULINUM TOXIN FOR THE TREATMENT OF FOCAL DYSTONIA AND HEMIFACIAL SPASM [J].
BRIN, MF ;
FAHN, S ;
MOSKOWITZ, C ;
FRIEDMAN, A ;
SHALE, HM ;
GREENE, PE ;
BLITZER, A ;
LIST, T ;
LANGE, D ;
LOVELACE, RE ;
MCMAHON, D .
MOVEMENT DISORDERS, 1987, 2 (04) :237-254
[3]   BOTULINUM TOXIN IN THE TREATMENT OF MYOFASCIAL PAIN SYNDROME [J].
CHESHIRE, WP ;
ABASHIAN, SW ;
MANN, JD .
PAIN, 1994, 59 (01) :65-69
[4]   CHRONIC TENSION HEADACHE - TREATED WITH AMITRIPTYLINE - DOUBLE-BLIND STUDY [J].
DIAMOND, S ;
BALTES, BJ .
HEADACHE, 1971, 11 (03) :110-&
[5]  
Elston J S, 1988, Adv Neurol, V50, P579
[6]   THE EPIDEMIOLOGY OF HEADACHE IN GERMANY - A NATIONWIDE SURVEY OF A REPRESENTATIVE SAMPLE ON THE BASIS OF THE HEADACHE CLASSIFICATION OF THE INTERNATIONAL-HEADACHE-SOCIETY [J].
GOBEL, H ;
PETERSENBRAUN, M ;
SOYKA, D .
CEPHALALGIA, 1994, 14 (02) :97-106
[7]   DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BOTULINUM TOXIN INJECTIONS FOR THE TREATMENT OF SPASMODIC TORTICOLLIS [J].
GREENE, P ;
KANG, U ;
FAHN, S ;
BRIN, M ;
MOSKOWITZ, C ;
FLASTER, E .
NEUROLOGY, 1990, 40 (08) :1213-1218
[8]  
Guy W., 1976, ECDEU Assessment Manual for Psychopharmacology, V76, P217
[9]   The placebo effect in acute headache management: Ketorolac, meperidine, and saline in the emergency department [J].
Harden, RN ;
Gracely, RH ;
Carter, T ;
Warner, G .
HEADACHE, 1996, 36 (06) :352-356
[10]   The impact of work-related rehabilitation on the quality of life of patients with schizophrenia [J].
Holzner, B ;
Kemmler, G ;
Meise, U .
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 1998, 33 (12) :624-631